3 search results
- Current search:
- Tobacco, drugs & alcohol
- Other drugs
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 11 May 2015
Psychosocial interventions to reduce sedative use, abuse and dependence
Background In this Cochrane review we aimed to measure the effectiveness of psychosocial interventions for treating people who harmfully use, abuse or are dependent on benzodiazepines (BZDs). BZDs are a type of drug that can be used to treat people who have anxiety, panic disorder, insomnia and a range of other conditions. Long term use of BZDs is ... -
Cochrane EvidencePublished 8 Dec 2010
No evidence-based treatment option for inhalant dependence or abuse
Inhalants are being abused by large numbers of people throughout the world, particularly socio-economically disadvantaged children and adolescents. This agent can cause many brain problems, for example, abnormal movement, sensory impairment, learning/memory impairment. Authors aimed to search and determine risks, benefits and costs of a variety treatments ... -
Cochrane EvidencePublished 20 Apr 2005
There is currently no evidence to determine the best way to treat Mandrax dependence in adults.
Dependence and abuse of methaqualone, a type of sedative-hypnotic, is a major public health problem in parts of Africa and India. Treatment is highly variable and takes place in both in-patient and out-patient settings. Despite an extensive search of electronic databases, the internet, relevant conferences and contact with experts in the field, this ...
